Control Bionics Director Adds to Shareholding With On-Market Purchase
CBL: $0.052 +6.12% · MC: $29M
Control Bionics director Stephen Rix acquired one million shares on market, increasing his direct and indirect holding to 11 million shares. The purchase follows a separate company update reporting revenue growth through the September quarter and reaffirming expected revenue growth of 50% in FY27, weighted to the second half.

Comments